Author(s): Kitabata H, Waksman R, Warnack B
Abstract Share this page
Abstract Over the last decade, the introduction of drug-eluting stents has dramatically reduced restenosis and the need for repeat revascularization after implantation of metallic stents. Numerous concerns still remain, however, because of their permanent nature. Thus, the concept of bioresorbable temporary scaffolds composed of biocompatible materials has emerged as a potential alternative to permanent metal stents. Here we focus on metal alloys & discuss preclinical and clinical experiences with bioresorbable metal scaffolds. Copyright © 2014. Published by Elsevier Inc.
This article was published in Cardiovasc Revasc Med
and referenced in Journal of Biotechnology & Biomaterials